Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study Nature Medicine 2019;25:1096-1103
Ms all del azcar Los nuevos medicamentos GLP-1 han abierto nuevas formas de tratar el sobrepeso y la obesidad
18% of US respondents reported taking prescription drugs for weight loss in 2025, up from 10% in 2024 Source: Euromonitors Voice of the Consumer: Health and Nutrition Survey, fielded February 2024 Legacy weight loss brands turn their attention towards GLP-1 consumers Heritage weight loss companies are shifting focus to accommodate the GLP-1 consumer
If youre dealing with a higher BMI, struggle with blood sugar swings or find it tough to break out of a long-term plateau, youll probably hear about GLP-1s
Wellstar Health System was a key partner in launching our Georgia Lung Cancer Roundtable, whose primary goal is to improve screening rates and lung cancer outcomes
The most widely known GLP-1 is semaglutide, sold under the brand names Ozempic and Wegovy, which is associated with roughly 15% total body weight loss